Related Experiment Video
Updated: Jul 5, 2026
06:13
The Intra-Aortic Balloon Pump
Published on: February 5, 2021
Extra-aortic implantable counterpulsation pump in chronic heart failure
Sergei Mitnovetski1, Aubrey A Almeida, Althea Barr
1Department of Cardiothoracic Surgery, Monash Medical Centre, Clayton, Victoria, Australia. smitnovetski@hotmail.com
The Annals of Thoracic Surgery
|May 24, 2008
Summary
Extra-aortic counterpulsation offers a novel treatment for chronic heart failure. This implantable device improved quality of life for a patient with severe heart failure, prolonging survival.
Area of Science:
- Cardiology
- Medical Devices
- Heart Failure Management
Background:
- Chronic heart failure (CHF) is a debilitating condition with limited treatment options for refractory cases.
- Extra-aortic counterpulsation represents a novel therapeutic strategy for advanced heart failure.
Observation:
- A 73-year-old patient with severe, medically refractory heart failure was treated with an implantable extra-aortic counterpulsation pump.
- The patient had experienced a significant decline in quality of life due to heart failure symptoms.
Findings:
- The implantation of the extra-aortic counterpulsation device led to a marked improvement in the patient's quality of life.
- The device successfully prolonged the patient's survival by approximately seven months post-implantation.
Implications:
- Extra-aortic counterpulsation shows promise as a viable option for managing severe, refractory chronic heart failure.
- Further research into the long-term efficacy and safety of these devices is warranted, particularly regarding potential complications such as infection.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...